“Targeting Neurodegeneration in Alzheimer’s Disease: A Comprehensive Evaluation of Andrographolide as a Potential Therapeutic Agent in the Management and Treatment of Cognitive Decline” (2024) Journal of Internal Medicine and Pharmacology (JIMP), 1(02), pp. 20–32. doi:10.61920/jimp.v1i02.24.